Synthesis and antiviral activity of new thiazole, 1,2,4-triazol and oxindole derivatives
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
1347 20
Ultima descărcare din IBN:
2024-04-11 05:23
SM ISO690:2012
RADUL, Oleg, SUCMAN, Natalia, POGREBNOI, Serghei, BARBĂ, Alic, MACAEV, Fliur. Synthesis and antiviral activity of new thiazole, 1,2,4-triazol and oxindole derivatives . In: Chemistry Journal of Moldova, 2011, nr. 1(6), pp. 101-109. ISSN 1857-1727.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Chemistry Journal of Moldova
Numărul 1(6) / 2011 / ISSN 1857-1727 /ISSNe 2345-1688

Synthesis and antiviral activity of new thiazole, 1,2,4-triazol and oxindole derivatives

Pag. 101-109

Radul Oleg, Sucman Natalia, Pogrebnoi Serghei, Barbă Alic, Macaev Fliur
 
Institutul de Chimie al AŞM
 
 
Disponibil în IBN: 29 noiembrie 2013


Rezumat

The synthesis and antiviral activity evaluation of new derivatives of 2-aminothiazole, 1,2,4-triazole, as well as oxindoles has been realized. The synthesized compounds exhibited different cytotoxicity, in particular, oxindols 4 , 5 , 7 , 8 , 9, 10, 11, 12, 13, 58 as well as thiazole/triazole 73 and 75 turned out to be the most cytotoxic for MT-4 cell lines. The compounds 11, 12, 73, and 75 are more toxic than reference compound Efavirenz. As far as the antiviral activity is concerned, none of the title compounds turned out active against Reo-1, Sb-1, VSV, RSV, YFV and VV viruses. The results obtained against Bovine Viral Diarrhoea Virus (BVDV) showed that nine compounds (six from oxindol’s seria 6, 12, 13, 52, 56, 58 and three 73, 75, 77 of triazole homologues) resulted moderate active. Among all of them, the most potent compound was 52, with EC50 of 6.6 μM. Studies of effect of synthesized compounds against Coxsakie Virus (CVB-2) revealed that only two compounds, 13 and 73 exhibit moderate activity (EC50 >40 and >18 μM, respectively). It should be noticed that eleven compounds, 4, 5, 7, 8, 9, 10, 11, 12, 13, 58, and 75 showed moderate activity against HIV-1 (EC50 >16 – m >59μM).

Cuvinte-cheie
2-aminothiazole, oxindoles,

1, 2,

4-triazol

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-12139</doi_batch_id>
<timestamp>1713559949</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>idsi@asm.md</email_address>
</depositor>
<registrant>Institutul de Chimie al AŞM</registrant>
</head>
<body>
<journal>
<journal_metadata>
<full_title>Chemistry Journal of Moldova</full_title>
<issn media_type='print'>18571727</issn>
<doi_data>
<doi>10.19261</doi>
<resource>http://www.crossref.org/</resource>
</doi_data>
</journal_metadata>
<journal_issue>
<publication_date media_type='print'>
<year>2011</year>
</publication_date>
<issue>1(6)</issue>
</journal_issue>
<journal_article publication_type='full_text'><titles>
<title>Synthesis and antiviral activity of new
thiazole, 1,2,4-triazol and oxindole derivatives
</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>Oleg</given_name>
<surname>Radul</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Natalia</given_name>
<surname>Sucman</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Serghei</given_name>
<surname>Pogrebnoi</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Alic</given_name>
<surname>Barbă</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Fliur</given_name>
<surname>Macaev</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2011</year>
</publication_date>
<pages>
<first_page>101</first_page>
<last_page>109</last_page>
</pages>
</journal_article>
</journal>
</body>
</doi_batch>